Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.65 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.65 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.60 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.55 |
| ▸ | CTSB | P07858 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | RGS12 | O14924 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL69614 | 0.89 | CA2 (0.79) | CA2CAMK2AAKR1B1TSHRLMNA | |
| Hydrochloric Acid SCHEMBL6765874 | 0.86 | CA2 (0.75) | CA2CAMK2AAKR1B1TSHRLMNA | |
| Hydrochloric Acid SCHEMBL25180348 | 0.86 | CA2 (0.75) | CA2CAMK2AAKR1B1TSHRLMNA | |
| SCHEMBL68027 | 0.81 | LMNA (0.86) | CA2CAMK2AAKR1B1TSHRLMNA | |
| SCHEMBL2996429 | 0.81 | CA2 (0.68) | CA2CAMK2AAKR1B1TSHRLMNA | |
| SCHEMBL18427891 | 0.81 | LMNA (0.86) | CA2CAMK2AAKR1B1TSHRLMNA | |
| Oxalic Acid SCHEMBL30089202 | 0.80 | TSHR (0.58) | CA2CAMK2ATSHRALDH1A1TDP1 | |
| SCHEMBL23501410 | 0.80 | ALDH1A1 (0.61) | CA2CAMK2AAKR1B1TSHRLMNA | |
| SCHEMBL21585550 | 0.80 | PTGS1 (0.62) | CA2CAMK2AAKR1B1TSHRLMNA | |
| SCHEMBL2642144 | 0.79 | CA2 (0.65) | CA2CAMK2AAKR1B1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 552 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117843276-B | Multi-component composite steel slag grinding-aid excitant and preparation method thereof | 华新水泥股份有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-115536517-B | Preparation method of 4-hydroxymethylphenylacetic acid | 苏州昊帆生物股份有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-117843276-A | Multi-component composite steel slag grinding-aid excitant and preparation method thereof | 华新水泥股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-116675459-A | Preparation method of cementing material reinforcing agent with high compressive strength | 泉州市富霸新型材料科技发展有限公司 | 2023-09-01 | — | — | CN | claimed |
| CN-115536517-A | Preparation method of 4-hydroxymethyl phenylacetic acid | 苏州昊帆生物股份有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-114805601-A | Application of polypeptide analogue in anti-wrinkle and anti-aging | 深圳深创生物药业有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-113121436-B | Preparation method of nertadalal dimethyl sulfonate | 江苏艾立康医药科技有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-113121436-A | Preparation method of nertadalal dimethyl sulfonate | 江苏艾立康医药科技有限公司 | 2021-07-16 | — | — | CN | claimed |
| CN-112409445-A | Solid-phase synthesis method of snake venom-like tripeptide | 浙江湃肽生物有限公司 | 2021-02-26 | — | — | CN | claimed |
| US-10906933-B2 | Coupled peptide chain for dissolving poorly soluble polypeptides and application thereof for separation and purification in liquid chromatography | SPEC-CHEM INDUSTRY INC. (CN) | 2021-02-02 | — | — | US | claimed |
| CN-101911914-A | Culture medium for spore germination and seedling culturing of pteridophyte | UNIV CHINA GEOSCIENCES WUHAN | 2010-12-15 | — | — | CN | claimed |
| US-7166696-B2 | Solid phase synthesis supports and methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-01-23 | — | — | US | claimed |
| US-20040265899-A1 | Solid phase synthesis supports and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2004-12-30 | — | — | US | claimed |
| US-6787635-B2 | azlactone-functionalized support such as a crosslinked polymer containing an alkenyl azlactone; use making combinatorial libraries | 3M INNOVATIVE PROPERTIES COMPANY | 2004-09-07 | — | — | US | claimed |
| EP-1373167-A2 | SOLID PHASE SYNTHESIS SUPPORTS AND METHODS | 3M Innovative Properties Company (US) | 2004-01-02 | — | — | EP | claimed |
| US-20020173051-A1 | Solid phase synthesis supports and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2002-11-21 | — | — | US | claimed |
| WO-2002081078-A2 | SOLID PHASE SYNTHESIS SUPPORTS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2002-10-17 | — | — | WO | claimed |
| WO-1996030392-A1 | PROCESS FOR THE PRODUCTION OF COMBINATORIAL COMPOUND LIBRARIES | NOVARTIS AG (CH) | 1996-10-03 | — | — | WO | claimed |
| EP-0733213-A1 | PROCESS FOR THE PRODUCTION OF COMBINATORIAL COMPOUND LIBRARIES | Novartis AG (CH) | 1996-09-25 | — | — | EP | claimed |
| WO-1995016209-A1 | PROCESS FOR THE PRODUCTION OF COMBINATORIAL COMPOUND LIBRARIES | CIBA-GEIGY AG (CH) | 1995-06-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020173051-A1 | Solid phase synthesis supports and methods | FES, LSS, CCNK | CA2 4783/4885CAMK2A 4296/4885AKR1B1 2431/4885 |
| US-20040265899-A1 | Solid phase synthesis supports and methods | FES, LSS, CCNK | CA2 4783/4885CAMK2A 4296/4885AKR1B1 2431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.